DZ Bank’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-35
Closed -$3.4K 1023
2022
Q1
$3.4K Sell
35
-35
-50% -$4.62K ﹤0.01% 975
2021
Q4
$14.2K Buy
70
+16
+30% +$3.78K ﹤0.01% 1055
2021
Q3
$13.4K Hold
54
﹤0.01% 948
2021
Q2
$22.4K Hold
54
﹤0.01% 920
2021
Q1
$21.1K Hold
54
﹤0.01% 879
2020
Q4
$30.9K Hold
54
﹤0.01% 844
2020
Q3
$37.8K Buy
+54
New +$42.1K ﹤0.01% 815

Other funds holding BLUE

DZ Bank's BLUE Position: Q2 2022 in Review

DZ Bank sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 35 shares — an estimated $3.4K sold.

DZ Bank first reported a position in BLUE in Q3 2020 and held it in 7 quarters. The position peaked at $37.8K in Q3 2020. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • DZ Bank reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • DZ Bank sold 35 bluebird bio shares in Q2 2022, an estimated $3.4K.
  • DZ Bank first reported a position in bluebird bio in Q3 2020 and held it in 7 quarters.
  • DZ Bank's bluebird bio position peaked at $37.8K in Q3 2020.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on DZ Bank's 13F filing for Q2 2022, filed 15 Aug 2022.